Pulmonary hypoxic vasoconstriction: not affected by chemical sympathectomy

Area of Science:

• Pulmonary Physiology
• Cardiovascular Research
• Pharmacology

Background:

• Hypoxic pulmonary vasoconstriction (HPV) is a critical mechanism for matching ventilation and perfusion in the lungs.
• The role of the sympathetic nervous system in modulating HPV is not fully understood.
• Chemical sympathectomy using 6-hydroxydopamine (6-OHDA) is a method to deplete catecholamines and assess sympathetic influence.

Purpose of the Study:

• To investigate the impact of chemical sympathectomy with 6-OHDA on regional alveolar HPV.
• To determine the effect of 6-OHDA on global hypoxic pulmonary vasoconstriction (HPV).
• To assess the efficacy of 6-OHDA in blocking sympathetic nervous system activity.

Main Methods:

• Eight dogs were used, with one lung ventilated with nitrogen for hypoxic challenge and the other with oxygen.
• Lung perfusion distribution was measured using 133Xe and external counters.
• Pulmonary vascular resistance (PVR) was monitored during global hypoxia before and after 6-OHDA administration.
• Tyramine injection was used to confirm effective sympathectomy.

Main Results:

• Regional alveolar hypoxia reduced test lung perfusion by 32.4% before 6-OHDA and by 27.3% after 6-OHDA.
• Global hypoxia increased PVR by 106% before 6-OHDA and by 90% after 6-OHDA.
• Tyramine did not increase PVR or systemic blood pressure post-6-OHDA, confirming successful sympathectomy.

Conclusions:

• Chemical sympathectomy with 6-OHDA did not substantially block regional alveolar hypoxic vasoconstriction.
• Global hypoxic pulmonary vasoconstriction was also not significantly inhibited by 6-OHDA.
• These findings suggest that the sympathetic nervous system plays a limited role in mediating HPV in this canine model.